S&P Futures
2,436.25
+4.50 (+0.19%)Dow Futures
21,371.00
+23.00 (+0.11%)
| Previous Close | 2.42 |
| Open | 2.36 |
| Bid | 2.22 x 1500 |
| Ask | 3.00 x 4000 |
| Day's Range | 2.35 - 3.09 |
| 52 Week Range | 0.19 - 4.96 |
| Volume | 3,126,180 |
| Avg. Volume | 1,755,181 |
| Market Cap | 10.7M |
| Beta | 1.28 |
| PE Ratio (TTM) | -0.27 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Capital Cube•4 days ago
ETFs with exposure to Celsion Corp. : June 19, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- MarketWatch•7 days ago
Celsion's stock rockets after withdrawing stock offering
Shares of Celsion Corp. rocketed 42% in premarket trade Friday, after the cancer drug development company filed to withdraw plans for a stock offering. The company had originally filed on April 5 an S-1 ...
- MarketWatch•18 days ago
UPDATE: Celsion shares surge 74% on news of positive trial of ovarian cancer treatment
Shares of Celsion Corp. surged 73.7% in extremely heavy morning trade Monday, after the cancer drug developer said an early-stage trial of a treatment of ovarian cancer showed promising findings. The phase ...